Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 134   

Articles published

VRX 201.03 -2.92 (-1.43%)
price chart
Valeant Pharmaceuticals International Inc faces high execution risk
The market clearly likes Valeant Pharmaceuticals International Inc.'s aggressive acquisition strategy, as the stock continues to consistently move higher.
Waiting for Reversal: Dendreon Corporation (OTCMKTS:DNDNQ)  MicroCap Daily
Valeant Pharmaceuticals International Inc's biggest deal yet seen as a bet on ...
Valeant Pharmaceuticals International Inc.'s biggest acquisition, its US$10.1 billion purchase of Salix Pharmaceuticals Ltd.
Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash  Canada NewsWire (press release)
Valeant Pharmaceuticals to buy Salix for $10.1bn  Economic Times
Valeant Pharmaceuticals International Inc. exploring Salix Pharmaceuticals Ltd ...
Valeant Pharmaceuticals International Inc. is exploring a takeover of Salix Pharmaceuticals Ltd., people with knowledge of the matter said, in the wake of the U.S.
Valeant Pharmaceuticals (VRX) Eyes Salix Pharmaceuticals As A Potential ...  Bidness ETC
Valeant in talks to buy Salix Pharma: Bloomberg  Reuters
Will Pfizer Inc. Look to Buy Valeant Pharmaceuticals Intl Inc.?
There's no denying that the 2014 was the year of the acquisition in the pharmaceutical business. Big companies bought small companies; big companies bought even bigger companies.
Valeant Pharmaceuticals Announces Expiration Of Bid Deadline In Connection ...  Canada NewsWire (press release)
Barclays Initiates Coverage On Valeant Pharmaceuticals  Benzinga
Is Valeant Pharmaceuticals Intl Inc a $250 Stock?
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a long history of growing through acquisitions. In fact as I write this article it is rumoured to have secured financing to purchase Salix Pharmaceuticals.
Share Price of Valeant Pharmaceuticals Intl Inc Rally 3.09%  Ashburn Daily
Valuation Perspetives: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)  Stock Markets Daily
Wednesday Close Up: Valeant Pharmaceuticals International Inc , Canadian ...
Valeant Pharmaceuticals International Inc (TSE:VRX) has dropped 0.12% or 0.31 points in todays trading session. The shares opened at 251.7 with the volume touching 361,427 shares, the last trade was executed at 252.05.
Revenue Update on Valeant Pharmaceuticals Intl Inc
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced the earnings results for Fiscal Year 2014 and Quarter 4. The results came in during after-hours on February 22,2015.
Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity  Benzinga
Deals of the Day: Valeant's Inversion Advantage, GE's Alstom Hurdle  Wall Street Journal (blog)
Illumina, Inc., Walgreens Boots Alliance Inc, Valeant Pharmaceuticals Intl Inc ...
At the end of the fourth quarter, the second and third largest holdings in Viking Global's equity portfolio were represented by Walgreens Boots Alliance Inc (NASDAQ:WBA) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) respectively, both the subject of ...
Thursday Closing Bell: Valeant Pharmaceuticals International Inc , Canadian ...
Valeant Pharmaceuticals International Inc (TSE:VRX) ended the trading session with a gain of 0.9400% or 2.36 points. After commencing the session at 253.49, the stock maintained a fairly thin range.
Analyst Upgrades: Dollar General Corporation, Hewlett-Packard Company, and ...
Specifically, 11 of 13 covering analysts call Valeant Pharmaceuticals Intl Inc a "buy" or better, with the remaining two handing out "hold" opinions.